Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Does This Signal Trouble for Biogen's New Alzheimer's Drug?
Does This Signal Trouble for Biogen's New Alzheimer's Drug?
Does This Signal Trouble for Biogen's New Alzheimer's Drug?
Submitted by
admin
on June 19, 2023 - 10:21am
Source:
Motley Fool
News Tags:
Eisai
Biogen
Leqembi
Alzheimer's disease
Europe
Headline:
Does This Signal Trouble for Biogen's New Alzheimer's Drug?
snippet:
Some European Alzheimer’s experts are wary about the future of Biogen’s drug Leqembi in the region.
Regulators in Europe, the U.S., and Japan currently are reviewing the drug.
Do Not Allow Advertisers to Use My Personal information
